{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:09:35Z","timestamp":1778872175331,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Women with a history of breast cancer face an elevated risk of developing contralateral breast cancer (CBC). Although annual mammographic screening is recommended, its sensitivity is limited, particularly in younger women and those with dense breast tissue. This study assessed the potential of artificial intelligence (AI)-based computer-aided diagnosis (AI-CAD) to improve CBC detection in a cohort of breast cancer survivors and to enhance early CBC detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 454 women who developed CBC and 454 matched controls without recurrence. Mammograms were analyzed using AI-CAD software assigning abnormality scores from 0 to 100, with scores over 10 indicating CBC. Standalone AI predictions were compared with radiologists\u2019 initial assessments, and its ability to detect early signs of CBC in prior mammograms was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age of patients was 53 years; the majority (79.9%) had dense breast tissue. Standalone AI detected 271 CBC cases solely from mammography, achieving 6.2% higher sensitivity compared with radiologists (59.7% vs. 53.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). Notably, AI detected 66 CBC cases (14.5%) that radiologists had missed on mammographic assessment alone. With respect to earlier detection, 81 cases (29.9%) were identified on prior mammograms at a median of 13.3 (9.6\u201319.9) months before clinical diagnosis. Of these, 28 cases (10.3%) were detected more than 6 months before pathological confirmation, and 53 cases (19.6%) more than 1 year earlier.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AI-CAD may enhance the detection of CBC in breast cancer survivors and facilitate earlier identification on surveillance mammography. Further studies are needed to assess its integration into surveillance mammography and clinical impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19348-z","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:42:55Z","timestamp":1772804575000},"page":"5581-5589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Early Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using AI-Assisted Mammography"],"prefix":"10.1245","volume":"33","author":[{"given":"Ji-Jung","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhye","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Byoel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariya","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"6","key":"19348_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1053\/ejso.1999.0711","volume":"25","author":"J Kollias","year":"1999","unstructured":"Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25(6):584\u20139. https:\/\/doi.org\/10.1053\/ejso.1999.0711.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"19348_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41416-021-01417-7","volume":"125","author":"V Giannakeas","year":"2021","unstructured":"Giannakeas V, Lim DW, Narod SA. The risk of contralateral breast cancer: a SEER-based analysis. Br J Cancer. 2021;125(4):601\u201310. https:\/\/doi.org\/10.1038\/s41416-021-01417-7.","journal-title":"Br J Cancer"},{"issue":"1","key":"19348_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13058-021-01400-3","volume":"23","author":"C Ramin","year":"2021","unstructured":"Ramin C, Withrow DR, Davis Lynn BC, Gierach GL, Berrington de Gonzalez A. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992\u20132016. Breast Cancer Res. 2021;23(1):24. https:\/\/doi.org\/10.1186\/s13058-021-01400-3.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"19348_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.ejca.2004.03.010","volume":"40","author":"S Ciatto","year":"2004","unstructured":"Ciatto S, Miccinesi G, Zappa M. Prognostic impact of the early detection of metachronous contralateral breast cancer. Eur J Cancer. 2004;40(10):1496\u2013501. https:\/\/doi.org\/10.1016\/j.ejca.2004.03.010.","journal-title":"Eur J Cancer."},{"issue":"8","key":"19348_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/jama.2011.188","volume":"305","author":"N Houssami","year":"2011","unstructured":"Houssami N, Abraham LA, Miglioretti DL, et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305(8):790\u20139. https:\/\/doi.org\/10.1001\/jama.2011.188.","journal-title":"JAMA"},{"issue":"5","key":"19348_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.11927","volume":"7","author":"H Song","year":"2024","unstructured":"Song H, Tran TXM, Kim S, Park B. Risk factors and mortality among women with interval breast cancer vs screen-detected breast cancer. JAMA Netw Open. 2024;7(5):e2411927. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.11927.","journal-title":"JAMA Netw Open"},{"issue":"17","key":"19348_CR7","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1016\/j.ejca.2009.08.007","volume":"45","author":"W Lu","year":"2009","unstructured":"Lu W, Schaapveld M, Jansen L, et al. The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer. Eur J Cancer. 2009;45(17):3000\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2009.08.007.","journal-title":"Eur J Cancer."},{"issue":"2","key":"19348_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1148\/radiol.2018181371","volume":"290","author":"A Rodriguez-Ruiz","year":"2019","unstructured":"Rodriguez-Ruiz A, Krupinski E, Mordang JJ, et al. Detection of breast cancer with mammography: effect of an artificial intelligence support system. Radiology. 2019;290(2):305\u201314. https:\/\/doi.org\/10.1148\/radiol.2018181371.","journal-title":"Radiology."},{"issue":"7788","key":"19348_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-019-1799-6","volume":"577","author":"SM McKinney","year":"2020","unstructured":"McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89\u201394. https:\/\/doi.org\/10.1038\/s41586-019-1799-6.","journal-title":"Nature."},{"issue":"10","key":"19348_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jamaoncol.2020.3321","volume":"6","author":"M Salim","year":"2020","unstructured":"Salim M, Wahlin E, Dembrower K, et al. External evaluation of 3 commercial artificial intelligence algorithms for independent assessment of screening mammograms. JAMA Oncol. 2020;6(10):1581\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3321.","journal-title":"JAMA Oncol."},{"issue":"9","key":"19348_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jnci\/djy222","volume":"111","author":"A Rodriguez-Ruiz","year":"2019","unstructured":"Rodriguez-Ruiz A, Lang K, Gubern-Merida A, et al. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J Natl Cancer Inst. 2019;111(9):916\u201322. https:\/\/doi.org\/10.1093\/jnci\/djy222.","journal-title":"J Natl Cancer Inst."},{"key":"19348_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.semcancer.2020.06.002","volume":"72","author":"I Sechopoulos","year":"2021","unstructured":"Sechopoulos I, Teuwen J, Mann R. Artificial intelligence for breast cancer detection in mammography and digital breast tomosynthesis: state of the art. Semin Cancer Biol. 2021;72:214\u201325. https:\/\/doi.org\/10.1016\/j.semcancer.2020.06.002.","journal-title":"Semin Cancer Biol."},{"issue":"3","key":"19348_CR13","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1016\/S2589-7500(20)30003-0","volume":"2","author":"HE Kim","year":"2020","unstructured":"Kim HE, Kim HH, Han BK, et al. Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study. Lancet Digit Health. 2020;2(3):e138\u201348. https:\/\/doi.org\/10.1016\/S2589-7500(20)30003-0.","journal-title":"Lancet Digit Health"},{"issue":"8","key":"19348_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1470-2045(23)00298-X","volume":"24","author":"K Lang","year":"2023","unstructured":"Lang K, Josefsson V, Larsson AM, et al. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lancet Oncol. 2023;24(8):936\u201344. https:\/\/doi.org\/10.1016\/S1470-2045(23)00298-X.","journal-title":"Lancet Oncol."},{"issue":"5","key":"19348_CR15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222733","volume":"307","author":"VA Arasu","year":"2023","unstructured":"Arasu VA, Habel LA, Achacoso NS, et al. Comparison of mammography AI algorithms with a clinical risk model for 5-year breast cancer risk prediction: an observational study. Radiology. 2023;307(5):e222733. https:\/\/doi.org\/10.1148\/radiol.222733.","journal-title":"Radiology"},{"key":"19348_CR16","unstructured":"D'Orsi CJ, Sickles EA, Mendelson EB, Morris EA. 2013 ACR BI-RADS Atlas: Breast Imaging Reporting and Data System. American College of Radiology; 2014."},{"issue":"11","key":"19348_CR17","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1001\/jamainternmed.2015.5231","volume":"175","author":"CD Lehman","year":"2015","unstructured":"Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL. Diagnostic accuracy of digital screening mammography with and without computer-aided detection. JAMA Intern Med. 2015;175(11):1828\u201337. https:\/\/doi.org\/10.1001\/jamainternmed.2015.5231.","journal-title":"JAMA Intern Med."},{"issue":"4","key":"19348_CR18","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1109\/TMI.2019.2945514","volume":"39","author":"N Wu","year":"2020","unstructured":"Wu N, Phang J, Park J, et al. Deep neural networks improve radiologists\u2019 performance in breast cancer screening. IEEE Trans Med Imaging. 2020;39(4):1184\u201394. https:\/\/doi.org\/10.1109\/TMI.2019.2945514.","journal-title":"IEEE Trans Med Imaging"},{"issue":"8","key":"19348_CR19","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1007\/s00330-021-07686-3","volume":"31","author":"K Lang","year":"2021","unstructured":"Lang K, Hofvind S, Rodriguez-Ruiz A, Andersson I. Can artificial intelligence reduce the interval cancer rate in mammography screening? Eur Radiol. 2021;31(8):5940\u20137. https:\/\/doi.org\/10.1007\/s00330-021-07686-3.","journal-title":"Eur Radiol."},{"key":"19348_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11050746","author":"AM Pereslucha","year":"2023","unstructured":"Pereslucha AM, Wenger DM, Morris MF, Aydi ZB. Invasive lobular carcinoma: a review of imaging modalities with special focus on pathology concordance. Healthcare (Basel). 2023. https:\/\/doi.org\/10.3390\/healthcare11050746.","journal-title":"Healthcare (Basel)"},{"issue":"6","key":"19348_CR21","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.acra.2023.12.006","volume":"31","author":"H Yoen","year":"2024","unstructured":"Yoen H, Jang MJ, Yi A, Moon WK, Chang JM. Artificial intelligence for breast cancer detection on mammography: Factors related to cancer detection. Acad Radiol. 2024;31(6):2239\u201347. https:\/\/doi.org\/10.1016\/j.acra.2023.12.006.","journal-title":"Acad Radiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19348-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:41Z","timestamp":1778869661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19348-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19348"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19348-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eun Kyung Park is a former employee of Lunit Inc. and declares that there are not any nonfinancial competing interests. Han-Byoel Lee and Wonshik Han report being a member on the board of directors of and holding stock and ownership interests at DCGen, Co., Ltd., not relevant to this study. Han-Byoel Lee also declares Research funding from Devicor Medical Product, Inc.; Consulting fees and honoraria from Alvogen, Boryung, Intuitive, Lilly, Need, Novartis, and Roche. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}